Free Trial

Microchip Technology (MCHP) Financials

Microchip Technology logo
$46.89 -0.23 (-0.49%)
Closing price 04/25/2025 04:00 PM Eastern
Extended Trading
$46.88 -0.01 (-0.02%)
As of 04/25/2025 07:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Microchip Technology

Annual Income Statements for Microchip Technology

This table shows Microchip Technology's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
369 324 165 255 356 571 349 1,286 2,238 1,907
Consolidated Net Income / (Loss)
365 324 165 255 356 571 349 1,286 2,238 1,907
Net Income / (Loss) Continuing Operations
365 324 171 255 356 571 349 1,286 2,238 1,907
Total Pre-Tax Income
346 281 90 737 205 150 340 1,483 2,910 2,366
Total Operating Income
426 352 276 936 714 647 998 1,850 3,116 2,571
Total Gross Profit
1,230 1,206 1,757 2,421 2,931 3,242 3,379 4,450 5,698 4,996
Total Revenue
2,147 2,173 3,408 3,981 5,350 5,274 5,438 6,821 8,439 7,634
Operating Revenue
2,147 2,173 3,408 3,981 5,350 5,274 5,438 6,821 8,439 7,634
Total Cost of Revenue
917 968 1,651 1,560 2,418 2,032 2,060 2,371 2,741 2,639
Operating Cost of Revenue
917 968 1,651 1,560 2,418 2,032 2,060 2,371 2,741 2,639
Total Operating Expenses
804 853 1,481 1,484 2,217 2,595 2,381 2,600 2,582 2,425
Selling, General & Admin Expense
275 302 500 452 683 677 610 719 798 734
Research & Development Expense
350 373 545 529 826 878 836 989 1,118 1,097
Amortization Expense
177 175 338 486 674 994 932 863 670 605
Other Special Charges / (Income)
2.84 4.00 99 18 34 47 1.70 30 -4.00 -12
Total Other Income / (Expense), net
-80 -71 -186 -199 -510 -497 -659 -367 -206 -205
Interest Expense
113 104 190 215 516 503 657 370 212 211
Interest & Investment Income
19 24 2.90 22 7.90 2.80 1.70 0.50 2.10 7.60
Other Income / (Expense), net
14 8.90 1.30 -5.80 -2.20 3.20 -3.80 2.80 3.80 -2.20
Income Tax Expense
-19 -43 -81 482 -151 -420 -9.90 197 672 459
Basic Earnings per Share
$1.84 $1.59 $0.76 $1.10 $1.51 $1.19 $0.67 $2.33 $4.07 $3.52
Weighted Average Basic Shares Outstanding
200.94M 203.40M 217.20M 232.90M 236.20M 477.70M 519.20M 552.30M 550.40M 542M
Diluted Earnings per Share
$1.65 $1.49 $0.71 $1.03 $1.42 $1.11 $0.65 $2.27 $4.02 $3.48
Weighted Average Diluted Shares Outstanding
223.56M 217.40M 234.80M 248.90M 249.90M 512.40M 541.20M 565.90M 557.30M 548M
Weighted Average Basic & Diluted Shares Outstanding
200.50M 203.90M 216.60M 232.20M 235.70M 245.33M 273.53M 554.50M 545.38M 536.89M
Cash Dividends to Common per Share
$1.43 $1.43 $1.44 $1.45 $1.46 $0.73 $0.75 $0.91 $1.26 $1.68

Quarterly Income Statements for Microchip Technology

This table shows Microchip Technology's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Net Income / (Loss) Attributable to Common Shareholders
507 546 580 604 666 667 419 155 129 78 -54
Consolidated Net Income / (Loss)
507 546 580 604 666 667 419 155 129 78 -54
Net Income / (Loss) Continuing Operations
507 546 580 604 666 667 419 155 129 78 -54
Total Pre-Tax Income
647 699 762 802 848 834 484 200 162 92 -46
Total Operating Income
701 755 812 848 903 885 529 254 219 147 31
Total Gross Profit
1,310 1,398 1,471 1,519 1,558 1,527 1,120 790 737 669 561
Total Revenue
1,964 2,073 2,169 2,233 2,289 2,254 1,766 1,326 1,241 1,164 1,026
Operating Revenue
1,964 2,073 2,169 2,233 2,289 2,254 1,766 1,326 1,241 1,164 1,026
Total Cost of Revenue
654 675 698 713 730 727 646 536 504 495 465
Operating Cost of Revenue
654 675 698 713 730 727 646 536 504 495 465
Total Operating Expenses
609 643 659 671 655 642 591 536 518 522 531
Selling, General & Admin Expense
189 202 203 204 204 197 172 162 151 157 158
Research & Development Expense
269 269 282 298 299 293 266 240 242 241 246
Amortization Expense
168 168 167 167 152 151 151 151 123 123 123
Other Special Charges / (Income)
-17 4.30 6.50 2.10 1.70 1.80 1.10 -17 2.60 1.50 3.50
Total Other Income / (Expense), net
-55 -56 -49 -46 -55 -51 -45 -54 -57 -55 -77
Interest Expense
57 55 53 48 56 50 49 55 62 59 69
Interest & Investment Income
0.10 0.20 0.80 1.00 1.50 1.60 2.00 2.50 2.80 2.00 1.70
Other Income / (Expense), net
1.70 -0.80 2.60 0.30 0.00 -3.10 2.10 -1.20 1.70 2.00 -9.70
Income Tax Expense
139 153 182 198 182 167 65 45 33 13 7.50
Basic Earnings per Share
$0.92 $0.99 $1.06 $1.10 $1.22 $1.23 $0.78 $0.29 $0.24 $0.15 ($0.10)
Weighted Average Basic Shares Outstanding
553.80M 551.50M 549.20M 550.40M 545.10M 543.10M 540.80M 542M 536.70M 536.70M 537.40M
Diluted Earnings per Share
$0.90 $0.98 $1.04 $1.10 $1.21 $1.21 $0.77 $0.29 $0.24 $0.14 ($0.10)
Weighted Average Diluted Shares Outstanding
561.50M 558.30M 555.40M 557.30M 551.40M 549.20M 546.50M 548M 542.80M 542M 537.40M
Weighted Average Basic & Diluted Shares Outstanding
552.48M 550.01M 547.80M 545.38M 544.33M 541.05M 540.39M 536.89M 536.51M 537.01M 537.82M
Cash Dividends to Common per Share
$0.28 $0.30 $0.33 $0.36 $0.38 $0.41 $0.44 $0.45 $0.45 $0.45 $0.46

Annual Cash Flow Statements for Microchip Technology

This table details how cash moves in and out of Microchip Technology's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents
-1,062 196 -1,183 -7.40 -473 -28 -121 37 -83 86
Net Cash From Operating Activities
378 468 1,060 1,420 1,675 1,544 1,917 2,843 3,621 2,893
Net Cash From Continuing Operating Activities
378 468 1,060 1,420 1,669 1,544 1,917 2,843 3,621 2,893
Net Income / (Loss) Continuing Operations
0.00 0.00 165 255 356 571 349 1,286 2,238 1,907
Consolidated Net Income / (Loss)
- - 165 255 356 571 349 1,286 2,238 1,907
Depreciation Expense
278 283 469 616 876 1,216 1,153 1,144 998 880
Amortization Expense
17 52 61 113 131 139 88 56 17 45
Non-Cash Adjustments To Reconcile Net Income
109 71 197 120 183 176 492 327 181 192
Changes in Operating Assets and Liabilities, net
-27 61 168 316 123 -557 -166 31 188 -130
Net Cash From Investing Activities
-678 800 -2,838 -1,012 -6,811 -133 -173 -478 -600 -392
Net Cash From Continuing Investing Activities
0.00 14 -2,838 -1,012 -6,811 -133 -173 -478 -600 -392
Purchase of Property, Plant & Equipment
- - -86 -214 -248 -139 -182 -492 -600 -399
Sale of Property, Plant & Equipment
0.00 14 23 10 0.20 3.20 8.30 14 0.90 0.40
Other Investing Activities, net
- - - - - - - 0.00 0.00 6.00
Net Cash From Financing Activities
99 -60 596 -415 4,664 -1,438 -1,864 -2,328 -3,105 -2,415
Net Cash From Continuing Financing Activities
-1,439 -286 596 -415 4,664 -1,438 -1,864 -2,328 -3,105 -2,415
Repayment of Debt
-1,167 -2.20 -3,255 -75 -4,368 -2,716 -8,979 -6,557 -7,405 -17,596
Repurchase of Common Equity
- - - - - 0.00 0.00 -426 -946 -982
Payment of Dividends
-286 -291 -315 -338 -344 -350 -388 -504 -695 -912
Issuance of Debt
0.00 0.00 4,182 0.00 9,406 1,638 7,544 5,173 5,935 17,055
Issuance of Common Equity
34 29 42 42 43 59 60 71 82 82
Other Financing Activities, net
-20 -22 -58 -44 -73 -69 -101 -85 -77 -63

Quarterly Cash Flow Statements for Microchip Technology

This table details how cash moves in and out of Microchip Technology's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Net Change in Cash & Equivalents
60 -72 -16 -55 37 -15 24 39 -4.60 -29 300
Net Cash From Operating Activities
840 793 1,278 710 993 616 853 430 377 44 272
Net Cash From Continuing Operating Activities
840 793 1,278 710 993 616 853 430 377 44 272
Net Income / (Loss) Continuing Operations
507 546 580 604 666 667 419 155 129 78 -54
Consolidated Net Income / (Loss)
507 546 580 604 666 667 419 155 129 78 -54
Depreciation Expense
259 252 244 243 223 219 219 218 189 188 187
Amortization Expense
4.10 4.20 4.20 4.20 3.90 4.90 16 20 19 14 25
Non-Cash Adjustments To Reconcile Net Income
47 41 48 44 54 49 45 43 44 46 -76
Changes in Operating Assets and Liabilities, net
23 -50 402 -186 46 -323 154 -6.50 -3.50 -283 189
Net Cash From Investing Activities
-154 -131 -164 -151 -141 -94 -86 -71 -126 -64 -42
Net Cash From Continuing Investing Activities
-154 -131 -164 -151 -141 -94 -86 -71 -126 -64 -42
Purchase of Property, Plant & Equipment
-154 -131 -164 -151 -141 -94 -87 -76 -126 -67 -42
Other Investing Activities, net
- - - - 0.00 0.40 1.10 4.90 0.10 2.40 -0.10
Net Cash From Financing Activities
-627 -735 -1,130 -614 -815 -537 -743 -320 -256 -8.40 71
Net Cash From Continuing Financing Activities
-627 -735 -1,130 -614 -815 -537 -743 -320 -256 -8.40 71
Repayment of Debt
-1,579 -1,784 -1,975 -2,067 -3,050 -4,696 -2,954 -6,896 -4,653 -2,534 -5,883
Repurchase of Common Equity
-195 -247 -230 -274 -140 -340 -115 -387 -73 -17 -6.50
Payment of Dividends
-153 -166 -180 -196 -209 -223 -237 -243 -243 -244 -245
Issuance of Debt
1,306 1,459 1,256 1,914 2,585 4,711 2,563 7,196 4,823 2,781 6,205
Issuance of Common Equity
13 24 17 28 15 25 17 24 13 21 12
Other Financing Activities, net
-20 -21 -17 -19 -16 -15 -17 -15 -124 -15 -12

Annual Balance Sheets for Microchip Technology

This table presents Microchip Technology's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Total Assets
4,781 5,538 7,687 8,257 18,350 17,426 16,479 16,200 16,370 15,873
Total Current Assets
2,665 3,097 2,305 3,356 2,215 2,217 2,145 2,453 3,069 3,013
Cash & Equivalents
608 2,093 909 901 429 401 280 317 234 320
Accounts Receivable
274 290 478 564 881 934 998 1,073 1,305 1,144
Inventories, net
279 307 417 476 712 686 665 854 1,325 1,316
Other Current Assets
47 12 59 120 192 195 201 206 205 234
Plant, Property, & Equipment, net
582 609 683 768 997 876 855 968 1,178 1,195
Total Noncurrent Assets
1,535 1,832 4,699 4,133 15,139 14,333 13,479 12,779 12,123 11,666
Goodwill
571 1,013 2,299 2,299 6,664 6,665 6,671 6,674 6,674 6,675
Intangible Assets
504 606 2,148 1,662 6,686 5,702 4,795 4,043 3,369 2,782
Noncurrent Deferred & Refundable Income Taxes
0.00 15 69 100 1,677 1,749 1,749 1,797 1,623 1,597
Other Noncurrent Operating Assets
76 79 75 72 112 217 264 265 457 612
Total Liabilities & Shareholders' Equity
4,781 5,538 7,687 8,257 18,350 17,426 16,479 16,200 16,370 15,873
Total Liabilities
2,720 3,387 4,416 4,977 13,063 11,841 11,142 10,305 9,857 9,215
Total Current Liabilities
354 382 705 2,017 2,375 1,637 2,410 1,399 3,119 2,519
Short-Term Debt
- 0.00 50 1,310 1,361 609 1,323 0.00 1,398 999
Accounts Payable
87 79 149 144 226 247 292 345 397 213
Accrued Expenses
101 119 213 230 787 782 794 1,054 1,324 1,307
Total Noncurrent Liabilities
2,366 3,005 3,712 2,960 10,688 10,203 8,732 8,906 6,738 6,696
Long-Term Debt
1,827 2,453 2,901 1,758 8,946 8,873 7,581 7,687 5,042 5,000
Noncurrent Deferred Revenue
114 111 185 755 756 668 690 705 706 649
Noncurrent Deferred & Payable Income Tax Liabilities
381 399 409 206 706 319 44 40 43 29
Other Noncurrent Operating Liabilities
43 41 217 241 280 343 417 474 948 1,018
Total Equity & Noncontrolling Interests
2,045 2,151 3,271 3,280 5,288 5,586 5,337 5,895 6,514 6,658
Total Preferred & Common Equity
2,045 2,151 3,271 3,280 5,288 5,586 5,337 5,895 6,514 6,658
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
2,045 2,151 3,271 3,280 5,288 5,586 5,337 5,895 6,514 6,658
Common Stock
1,000 1,392 2,538 2,563 2,680 2,675 2,404 2,537 2,414 2,483
Retained Earnings
1,550 1,583 1,479 1,397 3,211 3,432 3,394 4,175 5,764 6,760
Treasury Stock
-516 -820 -732 -663 -582 -501 -434 -796 -1,660 -2,582
Accumulated Other Comprehensive Income / (Loss)
11 -3.36 -14 -18 -21 -22 -26 -21 -4.10 -3.50

Quarterly Balance Sheets for Microchip Technology

This table presents Microchip Technology's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Total Assets
16,208 16,141 16,116 16,370 16,495 16,601 16,143 15,873 15,840 15,622 15,632
Total Current Assets
2,643 2,676 2,834 3,069 3,270 3,526 3,220 3,013 2,948 2,906 2,996
Cash & Equivalents
377 305 289 234 271 257 281 320 315 286 586
Accounts Receivable
1,145 1,133 1,175 1,305 1,465 1,706 1,398 1,144 1,096 1,044 857
Inventories, net
912 1,030 1,165 1,325 1,336 1,331 1,311 1,316 1,308 1,340 1,356
Other Current Assets
207 206 204 205 197 233 229 234 229 236 196
Plant, Property, & Equipment, net
995 1,088 1,114 1,178 1,186 1,207 1,208 1,195 1,196 1,171 1,152
Total Noncurrent Assets
12,570 12,377 12,169 12,123 12,039 11,868 11,715 11,666 11,695 11,546 11,484
Goodwill
6,674 6,674 6,674 6,674 6,675 6,675 6,675 6,675 6,682 6,682 6,685
Intangible Assets
3,869 3,705 3,545 3,369 3,253 3,089 2,937 2,782 2,776 2,655 2,518
Noncurrent Deferred & Refundable Income Taxes
1,748 1,692 1,630 1,623 1,604 1,576 1,538 1,597 1,601 1,638 1,704
Other Noncurrent Operating Assets
280 306 320 457 507 528 565 612 637 572 577
Total Liabilities & Shareholders' Equity
16,208 16,141 16,116 16,370 16,495 16,601 16,143 15,873 15,840 15,622 15,632
Total Liabilities
10,231 10,038 9,805 9,857 9,663 9,633 9,063 9,215 9,434 9,346 9,601
Total Current Liabilities
1,485 2,538 1,611 3,119 3,220 3,413 3,293 2,519 1,520 3,286 1,330
Short-Term Debt
- 999 - 1,398 1,399 1,661 1,662 999 0.00 1,946 0.00
Accounts Payable
305 380 355 397 281 284 242 213 196 204 196
Accrued Expenses
1,181 1,160 1,256 1,324 1,540 1,468 1,389 1,307 1,324 1,135 1,134
Total Noncurrent Liabilities
8,745 7,500 8,193 6,738 6,444 6,220 5,770 6,696 7,913 6,061 8,270
Long-Term Debt
7,564 6,305 6,589 5,042 4,632 4,415 4,033 5,000 6,168 4,477 6,750
Noncurrent Deferred Revenue
706 667 660 706 719 679 635 649 656 590 599
Noncurrent Deferred & Payable Income Tax Liabilities
41 42 40 43 42 34 33 29 32 30 23
Other Noncurrent Operating Liabilities
434 486 904 948 1,050 1,093 1,068 1,018 1,058 964 899
Total Equity & Noncontrolling Interests
5,978 6,103 6,312 6,514 6,831 6,969 7,080 6,658 6,406 6,276 6,032
Total Preferred & Common Equity
5,978 6,103 6,312 6,514 6,831 6,969 7,080 6,658 6,406 6,276 6,032
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
5,978 6,103 6,312 6,514 6,831 6,969 7,080 6,658 6,406 6,276 6,032
Common Stock
2,394 2,356 2,381 2,414 2,401 2,415 2,446 2,483 2,405 2,446 2,482
Retained Earnings
4,576 4,956 5,356 5,764 6,222 6,666 6,847 6,760 6,646 6,481 6,183
Treasury Stock
-975 -1,197 -1,408 -1,660 -1,787 -2,109 -2,209 -2,582 -2,641 -2,643 -2,630
Accumulated Other Comprehensive Income / (Loss)
-17 -12 -18 -4.10 -4.40 -2.80 -4.80 -3.50 -3.70 -7.80 -3.30

Annual Metrics and Ratios for Microchip Technology

This table displays calculated financial ratios and metrics derived from Microchip Technology's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
11.18% 1.22% 56.80% 16.81% 34.38% -1.41% 3.11% 25.42% 23.72% -9.53%
EBITDA Growth
10.54% -5.24% 15.87% 105.65% 3.62% 16.59% 11.53% 36.52% 35.47% -15.52%
EBIT Growth
-5.47% -17.79% -23.28% 235.80% -23.47% -8.68% 52.90% 86.30% 68.42% -17.66%
NOPAT Growth
7.15% -9.76% 29.16% -38.10% 283.29% 97.49% -58.16% 56.13% 49.42% -13.53%
Net Income Growth
-7.58% -11.34% -49.18% 55.16% 39.35% 60.33% -38.77% 267.92% 74.07% -14.78%
EPS Growth
-9.34% -9.70% -52.35% 45.07% 37.86% 60.33% -38.77% 249.23% 77.09% -13.43%
Operating Cash Flow Growth
45.51% 23.89% 126.53% 33.99% 17.98% -7.82% 24.14% 48.33% 27.38% -20.11%
Free Cash Flow Firm Growth
-102.54% -1,184.88% -1,305.39% 143.62% -1,099.55% 130.24% -41.34% 32.75% 27.80% -16.53%
Invested Capital Growth
45.61% 38.32% 135.54% -13.59% 265.26% -3.29% -4.81% -4.99% -4.10% -3.00%
Revenue Q/Q Growth
2.38% 0.67% 11.27% 2.57% 6.52% -0.06% 2.66% 5.85% 4.83% -10.62%
EBITDA Q/Q Growth
5.08% -5.62% 21.85% 7.20% 9.63% -2.78% 4.79% 8.61% 6.20% -14.76%
EBIT Q/Q Growth
0.41% -11.94% 38.75% 8.75% 9.88% -16.75% 16.80% 15.01% 10.62% -18.83%
NOPAT Q/Q Growth
8.29% -14.74% 94.50% -3.11% 35.88% 26.20% -12.74% 18.79% 6.22% -17.54%
Net Income Q/Q Growth
-3.41% -8.80% 73.15% 4.00% 8.54% -11.59% 4.83% 33.41% 8.02% -19.07%
EPS Q/Q Growth
-4.07% -8.02% 86.84% -0.96% 2.16% -11.59% 4.83% 30.46% 6.63% -20.18%
Operating Cash Flow Q/Q Growth
14.78% 24.15% 59.88% 2.67% 2.69% -2.01% 4.21% 11.73% -1.04% -8.81%
Free Cash Flow Firm Q/Q Growth
-115.48% 38.90% 13.19% -9.55% 3.40% 22.18% -9.12% 11.71% -2.04% -6.69%
Invested Capital Q/Q Growth
5.47% -4.46% -3.63% -2.08% -0.68% -0.88% -0.75% -0.70% 0.86% -1.25%
Profitability Metrics
- - - - - - - - - -
Gross Margin
57.27% 55.47% 51.56% 60.81% 54.80% 61.47% 62.13% 65.23% 67.52% 65.44%
EBITDA Margin
34.23% 32.04% 23.68% 41.69% 32.14% 38.01% 41.11% 44.75% 49.00% 45.75%
Operating Margin
19.82% 16.21% 8.09% 23.52% 13.35% 12.27% 18.35% 27.12% 36.93% 33.68%
EBIT Margin
20.46% 16.62% 8.13% 23.37% 13.31% 12.33% 18.28% 27.16% 36.97% 33.65%
Profit (Net Income) Margin
17.02% 14.90% 4.83% 6.42% 6.65% 10.82% 6.42% 18.85% 26.52% 24.98%
Tax Burden Percent
105.61% 115.14% 183.30% 34.64% 174.03% 379.39% 102.92% 86.71% 76.90% 80.60%
Interest Burden Percent
78.73% 77.88% 32.41% 79.24% 28.72% 23.13% 34.14% 80.03% 93.27% 92.10%
Effective Tax Rate
-5.61% -15.14% -89.98% 65.36% -74.03% -279.39% -2.92% 13.29% 23.10% 19.40%
Return on Invested Capital (ROIC)
36.14% 23.09% 15.31% 7.24% 12.87% 16.46% 7.18% 11.78% 18.45% 16.54%
ROIC Less NNEP Spread (ROIC-NNEP)
46.09% 47.09% -35.21% 1.51% -3.64% -3.42% -0.48% 7.80% 16.11% 13.76%
Return on Net Nonoperating Assets (RNNOA)
-18.66% -7.65% -9.24% 0.56% -4.56% -5.97% -0.78% 11.11% 17.62% 12.42%
Return on Equity (ROE)
17.48% 15.44% 6.07% 7.80% 8.31% 10.50% 6.40% 22.89% 36.07% 28.96%
Cash Return on Invested Capital (CROIC)
-1.00% -9.07% -65.48% 21.83% -101.15% 19.81% 12.11% 16.90% 22.63% 19.59%
Operating Return on Assets (OROA)
9.93% 7.00% 4.19% 11.67% 5.35% 3.64% 5.87% 11.34% 19.16% 15.93%
Return on Assets (ROA)
8.26% 6.28% 2.49% 3.20% 2.68% 3.19% 2.06% 7.87% 13.74% 11.83%
Return on Common Equity (ROCE)
17.48% 15.44% 6.07% 7.80% 8.31% 10.50% 6.40% 22.89% 36.07% 28.96%
Return on Equity Simple (ROE_SIMPLE)
17.87% 15.06% 5.03% 7.79% 6.73% 10.22% 6.55% 21.81% 34.35% 28.64%
Net Operating Profit after Tax (NOPAT)
450 406 524 324 1,243 2,455 1,027 1,604 2,396 2,072
NOPAT Margin
20.94% 18.67% 15.38% 8.15% 23.24% 46.55% 18.89% 23.51% 28.40% 27.14%
Net Nonoperating Expense Percent (NNEP)
-9.95% -24.00% 50.52% 5.73% 16.51% 19.88% 7.66% 3.98% 2.34% 2.78%
Cost of Revenue to Revenue
42.73% 44.53% 48.44% 39.19% 45.20% 38.53% 37.87% 34.77% 32.48% 34.56%
SG&A Expenses to Revenue
12.80% 13.88% 14.67% 11.36% 12.77% 12.83% 11.22% 10.54% 9.45% 9.62%
R&D to Revenue
16.28% 17.14% 16.00% 13.30% 15.45% 16.64% 15.38% 14.50% 13.25% 14.37%
Operating Expenses to Revenue
37.44% 39.26% 43.47% 37.29% 41.44% 49.20% 43.78% 38.12% 30.60% 31.76%
Earnings before Interest and Taxes (EBIT)
439 361 277 931 712 650 994 1,852 3,120 2,569
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
735 696 807 1,659 1,719 2,005 2,236 3,052 4,135 3,493
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
4.03 3.94 4.32 5.87 3.40 2.70 7.37 6.76 6.83 7.21
Price to Tangible Book Value (P/TBV)
8.50 15.91 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
3.84 3.89 4.14 4.84 3.36 2.86 7.24 5.84 5.27 6.29
Price to Earnings (P/E)
22.32 26.12 85.74 75.38 50.53 26.45 112.63 30.98 19.89 25.16
Dividend Yield
3.49% 3.45% 2.21% 1.76% 1.92% 2.33% 1.02% 1.27% 1.55% 1.89%
Earnings Yield
4.48% 3.83% 1.17% 1.33% 1.98% 3.78% 0.89% 3.23% 5.03% 3.97%
Enterprise Value to Invested Capital (EV/IC)
5.24 4.10 3.26 4.85 1.84 1.65 3.44 3.56 3.99 4.35
Enterprise Value to Revenue (EV/Rev)
3.60 3.84 4.59 5.06 5.21 4.58 8.82 6.92 6.01 7.03
Enterprise Value to EBITDA (EV/EBITDA)
10.51 11.99 19.40 12.13 16.20 12.06 21.46 15.46 12.26 15.36
Enterprise Value to EBIT (EV/EBIT)
17.57 23.13 56.49 21.63 39.13 37.17 48.25 25.47 16.25 20.89
Enterprise Value to NOPAT (EV/NOPAT)
17.18 20.59 29.88 62.04 22.41 9.85 46.71 29.42 21.16 25.90
Enterprise Value to Operating Cash Flow (EV/OCF)
20.45 17.86 14.77 14.18 16.64 15.66 25.03 16.60 14.00 18.55
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 20.59 0.00 8.18 27.69 20.52 17.25 21.87
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.89 1.14 0.90 0.94 1.95 1.70 1.67 1.30 0.99 0.90
Long-Term Debt to Equity
0.89 1.14 0.89 0.54 1.69 1.59 1.42 1.30 0.77 0.75
Financial Leverage
-0.41 -0.16 0.26 0.37 1.25 1.74 1.62 1.42 1.09 0.90
Leverage Ratio
2.12 2.46 2.44 2.43 3.11 3.29 3.10 2.91 2.62 2.45
Compound Leverage Factor
1.67 1.92 0.79 1.93 0.89 0.76 1.06 2.33 2.45 2.25
Debt to Total Capital
47.19% 53.28% 47.43% 48.33% 66.09% 62.93% 62.52% 56.60% 49.72% 47.40%
Short-Term Debt to Total Capital
0.00% 0.00% 0.80% 20.63% 8.73% 4.04% 9.29% 0.00% 10.79% 7.90%
Long-Term Debt to Total Capital
47.19% 53.28% 46.62% 27.70% 57.37% 58.89% 53.23% 56.60% 38.92% 39.51%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
52.81% 46.72% 52.57% 51.67% 33.91% 37.07% 37.48% 43.40% 50.28% 52.60%
Debt to EBITDA
2.49 3.52 3.66 1.85 5.99 4.73 3.98 2.52 1.56 1.72
Net Debt to EBITDA
-0.70 -0.16 1.91 0.53 5.74 4.53 3.86 2.41 1.50 1.63
Long-Term Debt to EBITDA
2.49 3.52 3.59 1.06 5.20 4.43 3.39 2.52 1.22 1.43
Debt to NOPAT
4.06 6.05 5.63 9.46 8.29 3.86 8.67 4.79 2.69 2.90
Net Debt to NOPAT
-1.15 -0.27 2.94 2.69 7.94 3.70 8.39 4.59 2.59 2.74
Long-Term Debt to NOPAT
4.06 6.05 5.54 5.42 7.20 3.61 7.38 4.79 2.10 2.41
Altman Z-Score
3.60 3.10 3.00 3.61 1.48 1.51 2.92 3.56 4.34 4.77
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
7.53 8.11 3.27 1.66 0.93 1.35 0.89 1.75 0.98 1.20
Quick Ratio
6.31 7.16 2.53 1.37 0.55 0.82 0.53 1.00 0.49 0.58
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-12 -159 -2,241 977 -9,769 2,954 1,733 2,300 2,940 2,454
Operating Cash Flow to CapEx
0.00% 0.00% 1,695.20% 697.25% 677.23% 1,135.98% 1,105.89% 595.08% 604.00% 726.63%
Free Cash Flow to Firm to Interest Expense
-0.11 -1.53 -11.78 4.55 -18.95 5.88 2.64 6.21 13.85 11.66
Operating Cash Flow to Interest Expense
3.35 4.50 5.57 6.60 3.25 3.07 2.92 7.67 17.06 13.74
Operating Cash Flow Less CapEx to Interest Expense
3.35 4.63 5.24 5.66 2.77 2.80 2.66 6.39 14.24 11.85
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.49 0.42 0.52 0.50 0.40 0.29 0.32 0.42 0.52 0.47
Accounts Receivable Turnover
8.32 7.71 8.87 7.64 7.41 5.81 5.63 6.59 7.10 6.23
Inventory Turnover
3.38 3.30 4.56 3.49 4.07 2.91 3.05 3.12 2.52 2.00
Fixed Asset Turnover
3.86 3.65 5.27 5.49 6.06 5.63 6.28 7.48 7.87 6.44
Accounts Payable Turnover
11.40 11.65 14.45 10.64 13.05 8.59 7.64 7.44 7.39 8.65
Days Sales Outstanding (DSO)
43.89 47.37 41.16 47.78 49.27 62.79 64.82 55.39 51.43 58.54
Days Inventory Outstanding (DIO)
107.85 110.55 80.05 104.51 89.65 125.50 119.68 116.94 145.11 182.65
Days Payable Outstanding (DPO)
32.01 31.34 25.27 34.31 27.96 42.50 47.78 49.03 49.38 42.18
Cash Conversion Cycle (CCC)
119.73 126.59 95.95 117.97 110.96 145.79 136.73 123.30 147.16 199.01
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
1,475 2,040 4,805 4,152 15,164 14,665 13,959 13,263 12,720 12,338
Invested Capital Turnover
1.73 1.24 1.00 0.89 0.55 0.35 0.38 0.50 0.65 0.61
Increase / (Decrease) in Invested Capital
462 565 2,765 -653 11,012 -499 -706 -696 -543 -382
Enterprise Value (EV)
7,721 8,353 15,654 20,123 27,861 24,174 47,977 47,190 50,705 53,667
Market Capitalization
8,236 8,464 14,114 19,251 17,985 15,094 39,355 39,822 44,499 47,987
Book Value per Share
$10.15 $10.57 $15.11 $14.00 $22.31 $23.32 $19.82 $10.60 $11.89 $12.32
Tangible Book Value per Share
$4.81 $2.61 ($5.44) ($2.91) ($34.02) ($28.31) ($22.76) ($8.67) ($6.44) ($5.18)
Total Capital
3,872 4,604 6,221 6,348 15,595 15,068 14,241 13,582 12,954 12,658
Total Debt
1,827 2,453 2,951 3,068 10,307 9,482 8,904 7,687 6,440 6,000
Total Long-Term Debt
1,827 2,453 2,901 1,758 8,946 8,873 7,581 7,687 5,042 5,000
Net Debt
-515 -111 1,540 872 9,876 9,079 8,622 7,368 6,206 5,680
Capital Expenditures (CapEx)
0.00 -14 63 204 247 136 173 478 600 398
Debt-free, Cash-free Net Working Capital (DFCFNWC)
352 269 348 452 770 786 777 734 1,115 1,173
Debt-free Net Working Capital (DFNWC)
2,311 2,715 1,651 2,649 1,201 1,189 1,059 1,054 1,349 1,493
Net Working Capital (NWC)
2,311 2,715 1,601 1,339 -160 580 -264 1,054 -49 494
Net Nonoperating Expense (NNE)
84 82 359 69 887 1,884 678 318 159 165
Net Nonoperating Obligations (NNO)
-570 -111 1,534 872 9,876 9,079 8,622 7,368 6,206 5,680
Total Depreciation and Amortization (D&A)
296 335 530 729 1,007 1,354 1,242 1,200 1,015 924
Debt-free, Cash-free Net Working Capital to Revenue
16.38% 12.36% 10.20% 11.36% 14.40% 14.90% 14.28% 10.76% 13.21% 15.37%
Debt-free Net Working Capital to Revenue
107.62% 124.91% 48.43% 66.54% 22.45% 22.54% 19.46% 15.45% 15.98% 19.56%
Net Working Capital to Revenue
107.62% 124.91% 46.97% 33.63% -2.99% 10.99% -4.86% 15.45% -0.58% 6.47%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.92 $0.80 $0.38 $0.55 $0.76 $1.20 $0.68 $2.33 $4.07 $3.52
Adjusted Weighted Average Basic Shares Outstanding
401.87M 406.77M 434.39M 465.80M 472.40M 477.80M 519.20M 552.30M 550.40M 542M
Adjusted Diluted Earnings per Share
$0.83 $0.75 $0.36 $0.52 $0.71 $1.12 $0.65 $2.27 $4.02 $3.48
Adjusted Weighted Average Diluted Shares Outstanding
447.12M 434.78M 469.61M 497.80M 499.80M 512.40M 541.20M 565.90M 557.30M 548M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.76 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
404.65M 429.63M 458.80M 470.07M 475.85M 490.66M 547.06M 554.50M 545.38M 536.89M
Normalized Net Operating Profit after Tax (NOPAT)
300 249 262 668 524 486 700 1,629 2,393 2,062
Normalized NOPAT Margin
13.97% 11.48% 7.69% 16.77% 9.79% 9.21% 12.87% 23.89% 28.36% 27.01%
Pre Tax Income Margin
16.11% 12.94% 2.64% 18.52% 3.82% 2.85% 6.24% 21.73% 34.48% 30.99%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
3.90 3.47 1.46 4.33 1.38 1.29 1.51 5.00 14.70 12.20
NOPAT to Interest Expense
3.99 3.90 2.75 1.51 2.41 4.88 1.56 4.33 11.29 9.84
EBIT Less CapEx to Interest Expense
3.90 3.61 1.13 3.38 0.90 1.02 1.25 3.71 11.88 10.31
NOPAT Less CapEx to Interest Expense
3.99 4.04 2.43 0.56 1.93 4.61 1.30 3.04 8.47 7.95
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
78.42% 89.87% 191.62% 132.15% 96.77% 61.36% 111.13% 39.19% 31.07% 47.80%
Augmented Payout Ratio
78.42% 89.87% 191.62% 132.15% 96.77% 61.36% 111.13% 72.30% 73.34% 99.30%

Quarterly Metrics and Ratios for Microchip Technology

This table displays calculated financial ratios and metrics derived from Microchip Technology's official financial filings.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
25.12% 25.66% 23.43% 21.07% 16.55% 8.74% -18.60% -40.62% -45.76% -48.37% -41.89%
EBITDA Growth
46.97% 42.96% 27.43% 28.26% 16.91% 9.45% -27.84% -55.21% -62.11% -68.35% -69.57%
EBIT Growth
90.36% 81.89% 56.70% 54.57% 28.46% 16.92% -34.72% -70.26% -75.55% -83.15% -96.01%
NOPAT Growth
75.24% 55.06% 50.15% 27.22% 28.97% 19.96% -25.84% -69.26% -75.32% -82.25% -95.28%
Net Income Growth
100.63% 125.70% 64.48% 37.93% 31.39% 22.04% -27.76% -74.39% -80.60% -88.24% -112.79%
EPS Growth
100.00% 127.91% 67.74% 39.24% 34.44% 23.47% -25.96% -73.64% -80.17% -88.43% -112.99%
Operating Cash Flow Growth
33.42% 29.67% 49.74% -5.11% 18.18% -22.31% -33.23% -39.39% -62.03% -92.92% -68.18%
Free Cash Flow Firm Growth
16.23% 15.79% 21.62% -1.37% 10.92% -10.41% -57.81% -51.11% -60.40% -50.91% -44.14%
Invested Capital Growth
-4.39% -4.02% -5.58% -4.10% -4.34% -2.38% -0.93% -3.00% -2.64% -2.93% -2.40%
Revenue Q/Q Growth
6.47% 5.58% 4.63% 2.93% 2.50% -1.50% -21.67% -24.91% -6.37% -6.24% -11.84%
EBITDA Q/Q Growth
13.13% 4.53% 5.16% 3.13% 3.12% -2.13% -30.67% -35.98% -12.78% -18.24% -33.34%
EBIT Q/Q Growth
28.10% 7.30% 7.94% 4.19% 6.46% -2.35% -39.73% -52.53% -12.49% -32.70% -85.73%
NOPAT Q/Q Growth
9.55% 7.24% 4.74% 3.38% 11.06% -0.25% -35.25% -57.15% -10.84% -28.26% -82.78%
Net Income Q/Q Growth
15.83% 7.69% 6.24% 4.08% 10.33% 0.03% -37.11% -63.10% -16.42% -39.37% -168.37%
EPS Q/Q Growth
13.92% 8.89% 6.12% 5.77% 10.00% 0.00% -36.36% -62.34% -17.24% -41.67% -171.43%
Operating Cash Flow Q/Q Growth
12.40% -5.62% 61.11% -44.48% 39.99% -37.96% 38.48% -49.61% -12.30% -88.44% 522.71%
Free Cash Flow Firm Q/Q Growth
-3.63% -1.44% 19.72% -13.26% 8.38% -20.40% -43.61% 0.51% -12.23% -1.32% -35.83%
Invested Capital Q/Q Growth
-0.75% -0.48% -3.73% 0.86% -1.01% 1.56% -2.29% -1.25% -0.64% 1.26% -1.75%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
66.71% 67.43% 67.80% 68.05% 68.09% 67.76% 63.43% 59.58% 59.37% 57.44% 54.72%
EBITDA Margin
49.22% 48.73% 48.98% 49.08% 49.37% 49.05% 43.42% 37.02% 34.49% 30.07% 22.74%
Operating Margin
35.72% 36.42% 37.41% 37.98% 39.46% 39.26% 29.98% 19.12% 17.65% 12.60% 3.01%
EBIT Margin
35.80% 36.38% 37.53% 37.99% 39.46% 39.12% 30.10% 19.03% 17.79% 12.77% 2.07%
Profit (Net Income) Margin
25.83% 26.35% 26.75% 27.05% 29.12% 29.57% 23.74% 11.67% 10.42% 6.74% -5.22%
Tax Burden Percent
78.44% 78.13% 76.13% 75.33% 78.56% 79.97% 86.56% 77.47% 79.91% 85.68% 116.27%
Interest Burden Percent
91.98% 92.68% 93.61% 94.52% 93.93% 94.52% 91.12% 79.15% 73.28% 61.57% -217.45%
Effective Tax Rate
21.56% 21.87% 23.87% 24.67% 21.44% 20.03% 13.44% 22.53% 20.09% 14.32% 0.00%
Return on Invested Capital (ROIC)
15.01% 16.25% 17.66% 18.59% 21.10% 21.69% 17.66% 9.03% 7.48% 4.71% 0.81%
ROIC Less NNEP Spread (ROIC-NNEP)
14.46% 15.67% 17.12% 18.07% 20.43% 21.05% 16.99% 8.32% 6.69% 3.92% -0.49%
Return on Net Nonoperating Assets (RNNOA)
19.40% 19.83% 19.57% 19.77% 20.65% 20.64% 14.86% 7.51% 5.87% 3.54% -0.43%
Return on Equity (ROE)
34.41% 36.08% 37.24% 38.35% 41.75% 42.34% 32.52% 16.54% 13.35% 8.25% 0.38%
Cash Return on Invested Capital (CROIC)
18.11% 19.44% 23.11% 22.63% 24.29% 23.07% 20.95% 19.59% 15.06% 10.58% 6.42%
Operating Return on Assets (OROA)
15.90% 17.18% 18.79% 19.69% 21.15% 21.37% 15.94% 9.01% 7.25% 4.36% 0.62%
Return on Assets (ROA)
11.47% 12.44% 13.39% 14.02% 15.61% 16.16% 12.57% 5.53% 4.24% 2.30% -1.56%
Return on Common Equity (ROCE)
34.41% 36.08% 37.24% 38.35% 41.75% 42.34% 32.52% 16.54% 13.35% 8.25% 0.38%
Return on Equity Simple (ROE_SIMPLE)
25.76% 30.22% 32.82% 0.00% 35.09% 36.12% 33.28% 0.00% 21.38% 12.45% 5.12%
Net Operating Profit after Tax (NOPAT)
550 590 618 639 709 708 458 196 175 126 22
NOPAT Margin
28.02% 28.46% 28.49% 28.61% 31.00% 31.39% 25.95% 14.81% 14.11% 10.79% 2.11%
Net Nonoperating Expense Percent (NNEP)
0.56% 0.59% 0.54% 0.51% 0.67% 0.64% 0.67% 0.70% 0.79% 0.79% 1.30%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - 3.59% - - - 0.17%
Cost of Revenue to Revenue
33.29% 32.57% 32.20% 31.95% 31.91% 32.25% 36.57% 40.42% 40.63% 42.56% 45.28%
SG&A Expenses to Revenue
9.62% 9.76% 9.35% 9.11% 8.90% 8.72% 9.75% 12.20% 12.12% 13.49% 15.42%
R&D to Revenue
13.70% 12.96% 13.02% 13.36% 13.04% 12.98% 15.06% 18.12% 19.47% 20.68% 24.00%
Operating Expenses to Revenue
30.99% 31.01% 30.39% 30.07% 28.63% 28.50% 33.45% 40.46% 41.71% 44.84% 51.71%
Earnings before Interest and Taxes (EBIT)
703 754 814 848 903 882 532 252 221 149 21
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
967 1,010 1,062 1,096 1,130 1,106 767 491 428 350 233
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
5.16 5.31 5.91 6.83 6.97 5.97 6.74 7.21 7.63 6.86 5.11
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
4.27 4.24 4.63 5.27 5.43 4.65 5.59 6.29 7.42 7.84 6.47
Price to Earnings (P/E)
20.02 17.58 18.01 19.89 19.86 16.53 20.25 25.16 35.67 55.11 99.73
Dividend Yield
1.76% 1.81% 1.71% 1.55% 1.57% 1.93% 1.80% 1.89% 1.92% 2.24% 3.16%
Earnings Yield
5.00% 5.69% 5.55% 5.03% 5.03% 6.05% 4.94% 3.97% 2.80% 1.81% 1.00%
Enterprise Value to Invested Capital (EV/IC)
2.89 3.01 3.46 3.99 4.24 3.71 4.25 4.35 4.46 3.96 3.03
Enterprise Value to Revenue (EV/Rev)
5.27 5.16 5.42 6.01 6.09 5.30 6.22 7.03 8.31 8.95 7.77
Enterprise Value to EBITDA (EV/EBITDA)
11.31 10.75 11.20 12.26 12.42 10.79 12.96 15.36 19.60 24.18 24.60
Enterprise Value to EBIT (EV/EBIT)
17.39 15.60 15.46 16.25 16.08 13.76 16.79 20.89 29.00 42.68 57.49
Enterprise Value to NOPAT (EV/NOPAT)
20.73 19.21 19.33 21.16 20.88 17.74 21.14 25.90 35.55 51.38 74.92
Enterprise Value to Operating Cash Flow (EV/OCF)
12.45 12.18 11.92 14.00 14.14 13.19 16.75 18.55 24.03 28.88 32.94
Enterprise Value to Free Cash Flow (EV/FCFF)
15.59 15.16 14.53 17.25 17.06 15.88 20.20 21.87 29.24 36.92 46.61
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.27 1.20 1.04 0.99 0.88 0.87 0.80 0.90 0.96 1.02 1.12
Long-Term Debt to Equity
1.27 1.03 1.04 0.77 0.68 0.63 0.57 0.75 0.96 0.71 1.12
Financial Leverage
1.34 1.27 1.14 1.09 1.01 0.98 0.87 0.90 0.88 0.90 0.88
Leverage Ratio
2.83 2.74 2.65 2.62 2.55 2.50 2.41 2.45 2.44 2.43 2.42
Compound Leverage Factor
2.60 2.54 2.49 2.48 2.40 2.37 2.19 1.94 1.79 1.50 -5.27
Debt to Total Capital
55.86% 54.48% 51.07% 49.72% 46.89% 46.58% 44.58% 47.40% 49.05% 50.58% 52.81%
Short-Term Debt to Total Capital
0.00% 7.45% 0.00% 10.79% 10.87% 12.73% 13.01% 7.90% 0.00% 15.33% 0.00%
Long-Term Debt to Total Capital
55.86% 47.03% 51.07% 38.92% 36.01% 33.84% 31.57% 39.51% 49.05% 35.25% 52.81%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
44.14% 45.52% 48.93% 50.28% 53.11% 53.42% 55.42% 52.60% 50.95% 49.42% 47.19%
Debt to EBITDA
2.25 1.99 1.69 1.56 1.40 1.38 1.39 1.72 2.21 3.16 4.49
Net Debt to EBITDA
2.14 1.91 1.62 1.50 1.34 1.32 1.32 1.63 2.10 3.01 4.10
Long-Term Debt to EBITDA
2.25 1.72 1.69 1.22 1.08 1.00 0.98 1.43 2.21 2.20 4.49
Debt to NOPAT
4.12 3.56 2.92 2.69 2.36 2.27 2.27 2.90 4.01 6.71 13.68
Net Debt to NOPAT
3.92 3.41 2.79 2.59 2.25 2.18 2.15 2.74 3.80 6.41 12.49
Long-Term Debt to NOPAT
4.12 3.07 2.92 2.10 1.81 1.65 1.61 2.41 4.01 4.67 13.68
Altman Z-Score
2.88 3.00 3.51 3.88 4.20 3.88 4.38 4.29 4.26 3.70 2.92
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.78 1.05 1.76 0.98 1.02 1.03 0.98 1.20 1.94 0.88 2.25
Quick Ratio
1.03 0.57 0.91 0.49 0.54 0.58 0.51 0.58 0.93 0.40 1.08
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
1,155 1,138 1,363 1,182 1,281 1,020 575 578 507 501 321
Operating Cash Flow to CapEx
546.42% 606.42% 778.73% 470.49% 704.90% 656.23% 977.43% 565.05% 300.24% 65.47% 644.89%
Free Cash Flow to Firm to Interest Expense
20.44 20.55 25.81 24.89 22.76 20.44 11.69 10.49 8.21 8.47 4.66
Operating Cash Flow to Interest Expense
14.87 14.32 24.20 14.94 17.64 12.35 17.34 7.80 6.10 0.74 3.93
Operating Cash Flow Less CapEx to Interest Expense
12.15 11.96 21.09 11.76 15.14 10.47 15.57 6.42 4.07 -0.39 3.32
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.44 0.47 0.50 0.52 0.54 0.55 0.53 0.47 0.41 0.34 0.30
Accounts Receivable Turnover
6.73 7.21 7.65 7.10 6.72 6.30 6.64 6.23 5.14 4.00 4.22
Inventory Turnover
3.09 2.93 2.74 2.52 2.51 2.43 2.27 2.00 1.82 1.63 1.50
Fixed Asset Turnover
7.65 7.59 7.88 7.87 8.04 7.79 7.36 6.44 5.53 4.62 4.03
Accounts Payable Turnover
8.36 7.49 8.08 7.39 9.62 8.65 9.43 8.65 10.10 8.95 9.13
Days Sales Outstanding (DSO)
54.27 50.62 47.72 51.43 54.35 57.93 54.98 58.54 70.95 91.32 86.53
Days Inventory Outstanding (DIO)
118.22 124.47 133.10 145.11 145.63 150.20 160.49 182.65 200.01 223.43 243.38
Days Payable Outstanding (DPO)
43.65 48.70 45.16 49.38 37.96 42.19 38.69 42.18 36.13 40.80 39.97
Cash Conversion Cycle (CCC)
128.85 126.38 135.66 147.16 162.03 165.94 176.78 199.01 234.83 273.95 289.93
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
13,163 13,100 12,611 12,720 12,591 12,788 12,495 12,338 12,259 12,413 12,195
Invested Capital Turnover
0.54 0.57 0.62 0.65 0.68 0.69 0.68 0.61 0.53 0.44 0.39
Increase / (Decrease) in Invested Capital
-605 -548 -745 -543 -572 -312 -117 -382 -332 -375 -300
Enterprise Value (EV)
38,012 39,407 43,605 50,705 53,368 47,430 53,122 53,667 54,709 49,213 36,961
Market Capitalization
30,827 32,411 37,305 44,499 47,608 41,611 47,708 47,987 48,856 43,076 30,798
Book Value per Share
$10.78 $11.05 $11.48 $11.89 $12.53 $12.80 $13.09 $12.32 $11.93 $11.70 $11.23
Tangible Book Value per Share
($8.23) ($7.74) ($7.10) ($6.44) ($5.68) ($5.14) ($4.68) ($5.18) ($5.68) ($5.70) ($5.91)
Total Capital
13,542 13,407 12,900 12,954 12,862 13,044 12,776 12,658 12,574 12,699 12,781
Total Debt
7,564 7,304 6,589 6,440 6,031 6,076 5,695 6,000 6,168 6,423 6,750
Total Long-Term Debt
7,564 6,305 6,589 5,042 4,632 4,415 4,033 5,000 6,168 4,477 6,750
Net Debt
7,185 6,997 6,300 6,206 5,760 5,819 5,414 5,680 5,853 6,137 6,164
Capital Expenditures (CapEx)
154 131 164 151 141 94 87 76 126 67 42
Debt-free, Cash-free Net Working Capital (DFCFNWC)
779 829 934 1,115 1,178 1,518 1,308 1,173 1,113 1,280 1,080
Debt-free Net Working Capital (DFNWC)
1,158 1,136 1,223 1,349 1,449 1,775 1,589 1,493 1,428 1,566 1,666
Net Working Capital (NWC)
1,158 138 1,223 -49 50 114 -74 494 1,428 -380 1,666
Net Nonoperating Expense (NNE)
43 44 38 35 43 41 39 42 46 47 75
Net Nonoperating Obligations (NNO)
7,185 6,997 6,300 6,206 5,760 5,819 5,414 5,680 5,853 6,137 6,164
Total Depreciation and Amortization (D&A)
264 256 248 247 227 224 235 239 207 201 212
Debt-free, Cash-free Net Working Capital to Revenue
10.79% 10.86% 11.60% 13.21% 13.44% 16.97% 15.31% 15.37% 16.90% 23.29% 22.69%
Debt-free Net Working Capital to Revenue
16.05% 14.87% 15.19% 15.98% 16.53% 19.84% 18.60% 19.56% 21.68% 28.49% 35.01%
Net Working Capital to Revenue
16.05% 1.80% 15.19% -0.58% 0.57% 1.27% -0.86% 6.47% 21.68% -6.92% 35.01%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.92 $0.99 $1.06 $1.10 $1.22 $1.23 $0.78 $0.29 $0.24 $0.15 ($0.10)
Adjusted Weighted Average Basic Shares Outstanding
553.80M 551.50M 549.20M 550.40M 545.10M 543.10M 540.80M 542M 536.70M 536.70M 537.40M
Adjusted Diluted Earnings per Share
$0.90 $0.98 $1.04 $1.10 $1.21 $1.21 $0.77 $0.29 $0.24 $0.14 ($0.10)
Adjusted Weighted Average Diluted Shares Outstanding
561.50M 558.30M 555.40M 557.30M 551.40M 549.20M 546.50M 548M 542.80M 542M 537.40M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $1.10 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
552.48M 550.01M 547.80M 545.38M 544.33M 541.05M 540.39M 536.89M 536.51M 537.01M 537.82M
Normalized Net Operating Profit after Tax (NOPAT)
537 593 623 640 711 709 459 183 177 127 24
Normalized NOPAT Margin
27.34% 28.62% 28.71% 28.68% 31.06% 31.46% 26.01% 13.82% 14.27% 10.90% 2.35%
Pre Tax Income Margin
32.93% 33.72% 35.14% 35.91% 37.07% 36.98% 27.43% 15.06% 13.03% 7.86% -4.49%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
12.44 13.62 15.42 17.86 16.04 17.67 10.80 4.58 3.57 2.51 0.31
NOPAT to Interest Expense
9.74 10.65 11.70 13.45 12.60 14.18 9.31 3.56 2.83 2.13 0.31
EBIT Less CapEx to Interest Expense
9.72 11.25 12.31 14.68 13.54 15.79 9.03 3.20 1.54 1.39 -0.30
NOPAT Less CapEx to Interest Expense
7.01 8.29 8.59 10.27 10.10 12.30 7.54 2.18 0.80 1.00 -0.30
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
35.31% 31.92% 30.90% 31.07% 31.34% 32.09% 36.71% 47.80% 69.00% 123.62% 315.22%
Augmented Payout Ratio
75.62% 78.99% 75.87% 73.34% 68.51% 71.16% 73.57% 99.30% 135.76% 199.36% 471.92%

Frequently Asked Questions About Microchip Technology's Financials

When does Microchip Technology's financial year end?

According to the most recent income statement we have on file, Microchip Technology's fiscal year ends in March. Their fiscal year 2024 ended on March 31, 2024.

How has Microchip Technology's net income changed over the last 9 years?

Microchip Technology's net income appears to be on an upward trend, with a most recent value of $1.91 billion in 2024, rising from $365.33 million in 2015. The previous period was $2.24 billion in 2023.

What is Microchip Technology's operating income?
Microchip Technology's total operating income in 2024 was $2.57 billion, based on the following breakdown:
  • Total Gross Profit: $5.00 billion
  • Total Operating Expenses: $2.42 billion
How has Microchip Technology revenue changed over the last 9 years?

Over the last 9 years, Microchip Technology's total revenue changed from $2.15 billion in 2015 to $7.63 billion in 2024, a change of 255.6%.

How much debt does Microchip Technology have?

Microchip Technology's total liabilities were at $9.22 billion at the end of 2024, a 6.5% decrease from 2023, and a 238.8% increase since 2015.

How much cash does Microchip Technology have?

In the past 9 years, Microchip Technology's cash and equivalents has ranged from $234 million in 2023 to $2.09 billion in 2016, and is currently $319.70 million as of their latest financial filing in 2024.

How has Microchip Technology's book value per share changed over the last 9 years?

Over the last 9 years, Microchip Technology's book value per share changed from 10.15 in 2015 to 12.32 in 2024, a change of 21.4%.



This page (NASDAQ:MCHP) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners